Cardinal Health, Inc. (CAH)

CAH (NYSE)
$81.50
pos +0.00
+0.00%
Today's Range: 80.80 - 81.70 | CAH Avg Daily Volume: 0
Last Update: 11/26/14 - 4:02 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $80.98
52 Week Range: $62.55 - $81.70
Oustanding Shares: 330,962,000
Market Cap: 26,973,403,000
6-Month Chart
TheStreet Ratings Grade for CAH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
CAH Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for CAH:
EBITDA 0.00B
Revenue 0.00B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (06/15) FY (06/16)
Average Estimate $1.11 $1.15 $4.26 $4.79
Number of Analysts 11 10 11 12
High Estimate $1.17 $1.19 $4.32 $4.93
Low Estimate $1.04 $1.09 $4.19 $4.67
Prior Year $0.90 $1.01 $3.84 $4.26
Growth Rate (Year over Year) 23.74% 14.06% 10.84% 12.60%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

By

Jim Cramer

 | Nov 17, 2014 | 4:33 AM EST

There's a powerful collection of "what's working."

By

Jim Cramer

 | Oct 6, 2014 | 5:55 AM EDT

Hewlett-Packard's recent spin-off is a good idea.

bullishCardinal Health, Inc. price target raised at Credit Suisse

Aug 5, 2014 | 8:04 AM EDT

CAH price target raised from $76 to $80, Credit Suisse said. Outperform rating. Valuation call due to strong F4Q14 results.

By

Jim Cramer

 | Aug 4, 2014 | 11:45 AM EDT

These quality names look appealing on the basis of 30-week moving average.

bullishCardinal Health Inc. price target raised at UBS

Aug 4, 2014 | 7:56 AM EDT

CAH price target raised from $77 to $80, UBS said. Buy rating. Positive outlook on F4Q14 after peers reported strong results.

By

Jill Malandrino

 | Jul 10, 2014 | 9:36 AM EDT

Akers Biosciences makes rapid, point-of-care screening and testing products designed to rapidly bring health care information direct to the consumer or provider.

By

Jim Cramer

 | May 1, 2014 | 3:05 PM EDT

But three days like this and valuations will shift again.

updateBarclays Healthcare Conf.

Mar 13, 2014 | 6:54 AM EDT

Barclays Healthcare Conference

bullishCardinal Health numbers boosted at Credit Suisse

Feb 19, 2014 | 7:46 AM EST

Shares of CAH now seen reaching $80, according to Credit Suisse. Estimates also upped, given the company's new guidance. Outperform rating. 

Lights, Camera, ACTION! This move lately in GPRO has been stellar, up nearly 12% over the...
For just under two weeks MCD has been bumping up against a very solid wall of resista...
Texas Instruments is surging today. Shares are up over 2.7% and are moving further i...
Shares of Amazon (AMZN) have been trading within a set of Fibonacci retracements measured ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.